Evidence map›Paper›PMID 21339365›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

MyD88-dependent SHIP1 regulates proinflammatory signaling pathways in dendritic cells after monophosphoryl lipid A stimulation of TLR4.

Caglar Cekic, Carolyn R Casella, Duygu Sag, Frann Antignano, Joseph Kolb, Jill Suttles, Michael R Hughes, Gerald Krystal, Thomas C Mitchell

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Vaccines · 2023
    Article
  4. Review
  5. Mechanisms of TLR4-Mediated Autophagy and Nitroxidative Stress.Frontiers in cellular and infection microbiology · 2021
    Review
  6. Review
  7. Stroma: the forgotten cells of innate immune memory.Clinical and experimental immunology · 2018
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Immunopharmacology of lipid A mimetics.Advances in pharmacology (San Diego, Calif.) · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Caglar CekicDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Carolyn R Casella
Duygu Sag
Frann Antignano
Joseph Kolb
Jill Suttles
Michael R Hughes
Gerald Krystal
Thomas C Mitchell
University of Louisville · USBC Cancer Agency · CACellular Therapeutics (United Kingdom) · GBUniversity of British Columbia · CA

Funding

Adjuvant Functions of Detoxified LPSR01AI071047 · NIAID · UNIVERSITY OF LOUISVILLE · PI MITCHELL, THOMAS C. · 2008 to 2012
$1.8M
NIAID NIH HHS AI071047NIAID NIH HHS R01 AI071047
6 · The paper itself

Abstract

We previously showed that monophosphoryl lipid A (MLA) activates TLR4 in dendritic cells (DCs) in a Toll/IL-1R domain-containing adaptor inducing IFN-β (TRIF)-biased manner: MLA produced from Salmonella minnesota Re595 induced signaling events and expression of gene products that were primarily TRIF dependent, whereas MyD88-dependent signaling was impaired. Moreover, when tested in TRIF-intact/MyD88-deficient DCs, synthetic MLA of the Escherichia coli chemotype (sMLA) showed the same activity as its diphosphoryl, inflammatory counterpart (synthetic diphosphoryl lipid A), indicating that TRIF-mediated signaling is fully induced by sMLA. Unexpectedly, we found that the transcript level of one proinflammatory cytokine was increased in sMLA-treated cells by MyD88 deficiency to the higher level induced by synthetic diphosphoryl lipid A, which suggested MyD88 may paradoxically help restrain proinflammatory signaling by TRIF-biased sMLA. In this article, we demonstrate that sMLA induces MyD88 recruitment to TLR4 and activates the anti-inflammatory lipid phosphatase SHIP1 in an MyD88-dependent manner. At the same time, MyD88-dependent signaling activity at the level of IL-1R-associated kinase 1 is markedly reduced. Increased SHIP1 activity is associated with reductions in sMLA-induced IκB kinase α/β and IFN regulatory factor 3 activation and with restrained expression of their downstream targets, endothelin-1 and IFN-β, respectively. Results of this study identify a pattern that is desirable in the context of vaccine adjuvant design: TRIF-biased sMLA can stimulate partial MyD88 activity, with MyD88-dependent SHIP1 helping to reduce proinflammatory signaling in DCs.

Indexed as

Adjuvants, ImmunologicAnimalsBone Marrow CellsDendritic CellsEscherichia coliInflammation MediatorsInositol Polyphosphate 5-PhosphatasesLipid AMiceMice, 129 StrainMice, Inbred C57BLMice, KnockoutMice, TransgenicMyeloid Differentiation Factor 88Phosphatidylinositol-3,4,5-Trisphosphate 5-PhosphatasesPhosphoric Monoester HydrolasesAdjuvants, Immunologicdiphosphoryl lipid AInflammation MediatorsInositol Polyphosphate 5-PhosphatasesInpp5d protein, mouseLipid Amonophosphoryl lipid AMyd88 protein, mouseMyeloid Differentiation Factor 88Phosphatidylinositol-3,4,5-Trisphosphate 5-PhosphatasesPhosphoric Monoester HydrolasesTlr4 protein, mouseToll-Like Receptor 4

Identifiers

PMID21339365
PMCPMC3249415
OpenAlexW2105664859

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.